Related Experiment Videos
Multimodality therapy for esophageal cancer
A A Forastiere1, R F Heitmiller, L Kleinberg
1Department of Oncology and Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Chest
|October 23, 1997
Summary
New treatment strategies for esophageal cancer, including neoadjuvant chemotherapy, chemoradiotherapy, and definitive nonsurgical therapy, aim to improve patient survival by enhancing local control and reducing distant metastases.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Esophageal cancer survival has seen improvements due to evolving treatment strategies over the last 15 years.
- Current approaches focus on enhancing local-regional control and minimizing distant metastatic spread.
Purpose of the Study:
- To review and present the rationale, results, and current recommendations for different treatment strategies in esophageal cancer.
- To evaluate neoadjuvant chemotherapy, chemoradiotherapy followed by surgery, and definitive nonsurgical therapy.
Main Methods:
- Review of single-institution pilot trials and randomized comparative trials.
- Analysis of treatment approaches for esophageal cancer patients.
Main Results:
- Neoadjuvant chemotherapy and chemoradiotherapy followed by surgery improve local-regional control and decrease distant metastases.
- Nonsurgical therapy serves as a definitive treatment option for select patients without metastatic disease.
Conclusions:
- Multiple treatment strategies exist for esophageal cancer, offering improved survival outcomes.
- Current recommendations are based on evidence from various clinical trials, guiding treatment selection.